Drug Discovery and Development Researchers are vital professionals responsible for the early-stage identification and creation of new therapeutic drugs. Their work begins with understanding the biological basis of diseases, identifying potential drug targets, and screening chemical compounds or biologics that could modify disease processes. These researchers employ a wide range of techniques, including high-throughput screening, molecular modeling, and bioinformatics, to discover promising drug candidates. Their role is crucial in ensuring that novel compounds are not only effective but also safe for use in humans. The discovery process often involves collaboration across multiple disciplines, including chemistry, biology, and pharmacology.
Once promising drug candidates are identified, drug discovery and development researchers guide these compounds through the rigorous stages of preclinical and clinical testing. This includes optimizing drug formulations, determining appropriate dosages, and assessing pharmacokinetics and toxicity profiles. These researchers are responsible for advancing potential drugs from the laboratory to the clinic, ensuring compliance with regulatory standards and minimizing risks for patients. As the field of drug development evolves, these researchers are embracing new technologies such as artificial intelligence and precision medicine to streamline the process and create more targeted, effective therapies. Their work continues to push the boundaries of medical science, offering the potential to cure diseases and improve health outcomes on a global scale.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India